Transposition of the great arteries

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:216675
Who is this for?
Show terms as
27Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Transposition of the great arteries (TGA), also known as dextro-transposition of the great arteries (d-TGA), is a serious congenital heart defect in which the two main arteries leaving the heart are switched (transposed). The aorta, which normally carries oxygen-rich blood from the left ventricle to the body, instead arises from the right ventricle and carries oxygen-poor blood. The pulmonary artery, which normally carries oxygen-poor blood from the right ventricle to the lungs, instead arises from the left ventricle. This creates two parallel circuits rather than the normal series circulation, meaning oxygen-poor blood is recirculated through the body without passing through the lungs for oxygenation, while oxygen-rich blood recirculates through the lungs without being delivered to the body. Newborns with TGA typically present with severe cyanosis (bluish discoloration of the skin) shortly after birth, along with rapid breathing, poor feeding, and respiratory distress. Survival depends on the presence of some communication between the two circuits, such as a patent foramen ovale, atrial septal defect, ventricular septal defect, or patent ductus arteriosus, which allows some mixing of oxygenated and deoxygenated blood. Without intervention, TGA is fatal in the neonatal period. Immediate management often includes prostaglandin E1 infusion to maintain the patent ductus arteriosus and a balloon atrial septostomy (Rashkind procedure) to improve mixing of blood at the atrial level. The definitive treatment is the arterial switch operation (Jatene procedure), which is typically performed within the first two weeks of life and involves reconnecting the great arteries to their correct ventricles along with reimplantation of the coronary arteries. Long-term outcomes following the arterial switch operation are generally excellent, though lifelong cardiac follow-up is required to monitor for potential complications such as coronary artery stenosis, neoaortic valve regurgitation, or pulmonary artery stenosis. The etiology of TGA is considered multifactorial, with both genetic and environmental factors contributing, though the exact cause remains incompletely understood in most cases.

Also known as:

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Transposition of the great arteries.

View clinical trials →

No actively recruiting trials found for Transposition of the great arteries at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Transposition of the great arteries community →

Specialists

Showing 25 of 27View all specialists →
MM
Mark W Russell, MD
Specialist
PI on 1 active trial
NM
Nicole S Wilder, MD
Specialist
PI on 1 active trial
BM
Bernhard Kuhn, MD
NEW YORK CITY, NY
Specialist
PI on 2 active trials
VW
Victor WADLMANN
Specialist
PI on 1 active trial26 Transposition of the great arteries publications
TP
Tamas Kiss, MD, PhD
Budapest
Specialist

Rare Disease Specialist

PI on 1 active trial
KM
Kirk Kanter, MD
ATLANTA, GA
Specialist
PI on 2 active trials
DM
Dean B. Andropoulos, M.D.
HOUSTON, TX
Specialist
PI on 1 active trial
VP
Véronique Abadie, MD, PhD
Specialist
PI on 1 active trial
PM
Philip Roentgen, MD
Specialist
PI on 1 active trial
LM
Laura Dos Subirà, PhD MD
Specialist
PI on 1 active trial1 Transposition of the great arteries publication
JM
John Kheir, MD
BOSTON, MA
Specialist
PI on 2 active trials
JP
Joost P van Melle, MD, PhD
Specialist
PI on 1 active trial
MD
Magalie Ladouceur, Dr
Specialist
PI on 1 active trial
MM
Matthias Greutmann, MD
Specialist
PI on 1 active trial
JN
Jane Newburger
BOSTON, MA
Specialist
PI on 1 active trial209 Transposition of the great arteries publications
WM
Wendy M Book, MD
ATLANTA, GA
Specialist
PI on 1 active trial1 Transposition of the great arteries publication
RM
Ranjit M Aiyagari, MD
ANN ARBOR, MI
Specialist
PI on 1 active trial
GM
Gunnar Bentsen, MD
Specialist
PI on 2 active trials1 Transposition of the great arteries publication
WP
Werner Budts, M.D., Ph.D.
Specialist
PI on 1 active trial
VM
Vasilis Babaliaros, MD
ATLANTA, GA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Transposition of the great arteries.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Transposition of the great arteriesForum →

No community posts yet. Be the first to share your experience with Transposition of the great arteries.

Start the conversation →

Latest news about Transposition of the great arteries

Disease timeline:

New recruiting trial: Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)

A new clinical trial is recruiting patients for Transposition of the great arteries

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Transposition of the great arteries

What is Transposition of the great arteries?

Transposition of the great arteries (TGA), also known as dextro-transposition of the great arteries (d-TGA), is a serious congenital heart defect in which the two main arteries leaving the heart are switched (transposed). The aorta, which normally carries oxygen-rich blood from the left ventricle to the body, instead arises from the right ventricle and carries oxygen-poor blood. The pulmonary artery, which normally carries oxygen-poor blood from the right ventricle to the lungs, instead arises from the left ventricle. This creates two parallel circuits rather than the normal series circulation

How is Transposition of the great arteries inherited?

Transposition of the great arteries follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Transposition of the great arteries typically begin?

Typical onset of Transposition of the great arteries is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Transposition of the great arteries?

25 specialists and care centers treating Transposition of the great arteries are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.